Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susann Hasler

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Praxis|September 4, 2014
[Is initial antithrombotic therapy of acute deep vein thrombosis better as outpatient or inpatient?]Susann Hasler
Praxis|January 15, 2015
[Fecal calprotectin assessment cut-offs as outcome measures or screening tool in inflammatory bowel disease]Susann Hasler
Praxis|April 23, 2015
[Multimorbidity in primary care]Susann Hasler
Praxis|August 20, 2015
[Beta-lactam monotherapy in hospitalized pneumonia patients is not inferior to a combined therapy]Susann Hasler
Praxis|January 29, 2015
[Dabigatran and risk of bleeding]Susann Hasler
Praxis|October 30, 2014
[Cardiovascular polypharmacy does not lead to increased unplanned hospital admissions - a question of definition?]Susann Hasler
Therapeutische Umschau. Revue Therapeutique|November 26, 2019
[Allergy assessment: when and how?]Susann Hasler, Eugen Bersuch, Peter Schmid-Grendelmeier
Trials|August 27, 2015
Effect of a patient-centered drug review on polypharmacy in primary care patients: study protocol for a cluster-randomized controlled trialSusann Hasler, Oliver Senn, Thomas Rosemann, et al.
Swiss Medical Weekly|February 1, 2016
Types of abuse and risk factors associated with elder abuseLacher Simone, Albert Wettstein, Oliver Senn, et al.
Family Practice|February 26, 2015
Primary care in Switzerland gains strengthSima Djalali, Tatjana Meier, Susann Hasler, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Praxis|September 4, 2014
[Is initial antithrombotic therapy of acute deep vein thrombosis better as outpatient or inpatient?]Susann Hasler
Praxis|January 15, 2015
[Fecal calprotectin assessment cut-offs as outcome measures or screening tool in inflammatory bowel disease]Susann Hasler
Praxis|April 23, 2015
[Multimorbidity in primary care]Susann Hasler
Praxis|August 20, 2015
[Beta-lactam monotherapy in hospitalized pneumonia patients is not inferior to a combined therapy]Susann Hasler
Praxis|January 29, 2015
[Dabigatran and risk of bleeding]Susann Hasler
Praxis|October 30, 2014
[Cardiovascular polypharmacy does not lead to increased unplanned hospital admissions - a question of definition?]Susann Hasler
Therapeutische Umschau. Revue Therapeutique|November 26, 2019
[Allergy assessment: when and how?]Susann Hasler, Eugen Bersuch, Peter Schmid-Grendelmeier
Trials|August 27, 2015
Effect of a patient-centered drug review on polypharmacy in primary care patients: study protocol for a cluster-randomized controlled trialSusann Hasler, Oliver Senn, Thomas Rosemann, et al.
Swiss Medical Weekly|February 1, 2016
Types of abuse and risk factors associated with elder abuseLacher Simone, Albert Wettstein, Oliver Senn, et al.
Family Practice|February 26, 2015
Primary care in Switzerland gains strengthSima Djalali, Tatjana Meier, Susann Hasler, et al.
Pageof 2